CME Satellite Symposium

A CME Symposium during the 2026 Annual Meeting for the American Association of Heart Failure Nurses in San Diego, California.

AGENDA

3:50 pm           Introduction

                        Margaret Cuomo, NP (Chair)

3:53 pm           When Should I Think About Transthyretin Cardiac Amyloidosis

                        Margaret Cuomo, NP

4:08 pm           Diagnosis of ATTR-CM and Treatment with Disease-Modifying Therapies

                        Justin Grodin, MD, MPH

4:28 pm           ATTR-CM in HF: Questions and Answers for Real-World Practice

                        Margaret Cuomo, NP and Justin Grodin, MD, MPH

4:40 pm           Question and Answer

EDUCATIONAL OBJECTIVES

• Indicate red flags which raise suspicion for ATTR-CM and identify specific patient populations where the disease is prevalent

• Recognize the criteria for diagnosing ATTR-CM and interpret the evidence with disease-modifying therapies

• Discuss best use of HF GDMT in individuals with ATTR-CM

• Describe recommended monitoring of disease progression and summarize roles for HF nurses in overall management of ATTR-CM

Educational Grant

This program is supported by an independent educational grant provided by Alnylam.

CHAIR

Margaret Cuomo, NP

Columbia University Irving Medical Center

New York, New York

FACULTY

Justin Grodin, MD, MPH

Associate Professor of Medicine

Department of Internal Medicine – Division of Cardiology

University of Texas Southwestern Medical Center

Dallas, Texas